Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine plus ketamine versus ropivacaine alone for Cesarean pain
IRCT20221125056605N1Phase 3Completed
- Sponsor
- Vice-Chancellery for Research, Hormozgan University of Medical Sciences
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ropivacaine and ketamine in postoperative pain (2 arms), sponsored by Vice-Chancellery for Research, Hormozgan University of Medical Sciences. Started Mar 2024; status: completed.
02
Drugs
ropivacaineketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20221125056605N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221125056605N1.